Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
ARIADPharmaceuticals
Work at ARIADPharmaceuticals?
Add yourself to this profile
2937
ARIADPharmaceuticals
ARIAD Pharmaceuticals ($ARIA) is focused on medicines to transform the lives of cancer patients. Read our twitter policy on our site
Edit Profile
ariad.com
Technology
>
Biotechnology
Health Care
>
Medical
>
Pharmaceuticals
B2c
Founded in
1991
More info
Elsewhere
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Mobile.co
HubSpot
nuTonomy
Biogen
General Catalyst
Harvard University
Companies in the same industry
Pharmapod
Thermosome
eXIthera Pharmaceuticals
Verona Pharma Plc
3D Bio Holdings
Cyclica Inc.
Prexton Therapeutics SA
Bristol-Myers Squibb
Pearl Therapeutics
TetraGenetics
Alexa global traffic share
Twitter followers
Overview
Add info
Acquired by
09 Jan 2017
Takeda
$5,200,000,000
1
Locations
HQ
Cambridge
,
United States
Headquarters
$5,200,000,000
Xconomy
Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio
Health
Strategy
The Motley Fool
Why Ariad Pharmaceuticals, Nevsun Resources, and Ctrip.com International Slumped Today
Stock markets
Earnings
Health
The Motley Fool
Is It Time to Buy Ariad Pharmaceuticals' Stock?
Health
Stock markets
The Motley Fool
3 Charts Show Why Buying Ariad Pharmaceuticals May Be Risky
Earnings
Health
Stock markets
The Motley Fool
Why Ariad Pharmaceuticals Shares Jumped 11.2% In February
Earnings
Health
Stock markets
MIT
Raspberry Pi
ARM
Xconomy
Mobile.co
HubSpot
nuTonomy
Biogen
General Catalyst
Harvard University
Pharmapod
Cyclica Inc.
Bristol-Myers Squibb
Pearl Therapeutics
TetraGenetics
